{"id":"W2553811141","doi":"10.1182/blood.v106.11.349.349","title":"Maintenance Rituximab after CVP Results in Superior Clinical Outcome in Advanced Follicular Lymphoma (FL): Results of the E1496 Phase III Trial from the Eastern Cooperative Oncology Group and the Cancer and Leukemia Group B.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Hazard ratio; Internal medicine; Vincristine; Gastroenterology; Randomization; Cyclophosphamide; Prednisone; Surgery; Lymphoma; Chemotherapy; Confidence interval; Oncology; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001058659,0.0002616601,0.0009316796,0.00003573648,0.00007952187,0.00002578403,0.0001897985,0.0001787004,0.000007294648],"category_scores_gemma":[0.0006215742,0.0001150992,0.0001640816,0.0001831708,0.0005672416,0.00009204484,0.0001702283,0.000216087,0.000002329673],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002724766,"about_ca_system_score_gemma":0.0002568236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003826118,"about_ca_topic_score_gemma":0.01592799,"domain_scores_codex":[0.9971367,0.0005153214,0.001222833,0.0005699907,0.0002434035,0.0003117444],"domain_scores_gemma":[0.9976099,0.001402991,0.0002740236,0.0005697787,0.00005312561,0.00009024105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.527328,0.0126925,0.327143,0.00002196094,0.0006232408,0.0005032186,0.00739504,0.00001077607,0.0001743113,0.0002438267,0.0002593542,0.1236048],"study_design_scores_gemma":[0.7211743,0.001423715,0.2715134,0.0002826964,0.0003613833,0.00002627009,0.0004671554,0.0002863045,0.0002488439,0.00002934002,0.004064445,0.0001221411],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854187,0.004642186,0.000001437521,0.007228993,0.0002071621,0.002085404,0.0002523698,0.000009430015,0.000154323],"genre_scores_gemma":[0.9951901,0.001826637,0.0001859342,0.001736254,0.000298399,0.0006319071,0.00002330397,0.00001803439,0.00008936725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1938464,"threshold_uncertainty_score":0.8888192,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02303963769587453,"score_gpt":0.3321429067956527,"score_spread":0.3091032690997781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}